..I'm long AMPE, but if for whatever reason the Ampion data is negative, this is a $2.00 stock given how little cash thay have.
Short term you may be correct, but they have another plate appearance in NOV/DEC with Optina. Any support levels your looking at in case we strike out with Ampion??
PS... imprvemyavg will absolutely love this discussion!!!
only because its a rational discussion of possibilities GL2U
" but they have another plate appearance in NOV/DEC with Optina."
And don't forget Zertane! The great richard cavalli said on June 12 "And Zertane . . . we already heard in the recent UBS interview from Macaluso . . . they expect to announce the partner "VERY SOON".
Ampion is their flagship drug, so the results need to be positive. There unfortunately is a part of Wall Street that thinks Optina is a fairy tale.